ANNA TAYLOR: Open Payments
NPI 1205569258 · BEDFORD, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,270 in 212 payments from 18 companies in 2025. Trend: 2023 $86 · 2024 $1,470 · 2025 $4,270
Food & beverage: $3,934Education: $336
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $748 |
| Janssen Biotech, Inc. | 35 | $662 |
| Arcutis Biotherapeutics, Inc. | 23 | $562 |
| GENZYME CORPORATION | 10 | $294 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $284 |
| Organon LLC | 10 | $253 |
| Galderma Laboratories, L.P. | 19 | $221 |
| Amgen Inc. | 15 | $206 |
| UCB, Inc. | 8 | $182 |
| E.R. Squibb & Sons, L.L.C. | 12 | $154 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, Zoryve, RINVOQ, NEMLUVIO, OTEZLA, Bimzelx.
Industry payments across NH — which companies pay providers there.
